3-氟-5-甲氧基苯胺 | 2339-58-4

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 3-氟-5-甲氧基苯胺
• 英文名称: 3-fluoro-5-methoxyaniline
• CAS: 2339-58-4
• 化学式: C₇H₈FNO
• mdl: MFCD00077535
• 分子量: 141.145
• InChiKey: BHWSRJOKTBUWBN-UHFFFAOYSA-N

物化性质

• 沸点：
  226.2±20.0 °C(Predicted)
• 密度：
  1.176±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2922299090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Fluoro-5-methoxyaniline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Fluoro-5-methoxyaniline
CAS number: 2339-58-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H8FNO
Molecular weight: 141.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-氟-5-甲氧基苯胺 生成 3-溴-5-氟苯甲醚
  参考文献：
  名称：

  Methods for treating hypertension or inhibiting gastric secretion

  摘要：

  描述了3-羟基-α-(1-氨基乙基)-苄醇的新衍生物，特别是赤霉酸和橘霉酸3-羟基-α-[;1-氨基乙基];-苄醇的3-醚衍生物及其纯对映体。还展示了上述鉴定化合物的制备过程。

  公开号：

  US03671636A1
• 作为产物：
  描述：

  3-氯-5-氟苯甲醚 在 ammonium hydroxide 、 potassium phosphate 、 copper(l) iodide 、 N1,N2-bis(5-methyl-[1,1'-biphenyl]-2-yl)oxalamide 作用下， 以 水 、 二甲基亚砜 为溶剂， 反应 24.0h， 以79%的产率得到3-氟-5-甲氧基苯胺
  参考文献：
  名称：

  通过CuI /羟基二酰胺催化的芳基氯化物和氨气耦合组装伯（杂）芳胺

  摘要：

  已经开发了一种通用的和实用的催化体系，用于用含水或气态氨将芳基氯化物进行芳基胺化，其中CuI为催化剂，双芳基草酸二酰胺为配体。反应在105–120°C下进行，以高收率提供具有各种官能团的各种伯（杂）芳基胺。

  DOI：

  10.1021/acs.orglett.5b03230

文献信息

• CHROMENONE DERIVATIVES
  申请人：BARLAAM Bernard Christophe

  公开号：US20110098271A1

  公开（公告）日：2011-04-28

  The invention concerns chromenone derivatives of Formula I or a pharmaceutically-acceptable salts thereof, wherein each of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , n and R 9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.

  这项发明涉及公式I的香豆素衍生物或其药用盐，其中R1、R2、R3、R4、R5、R6、R7、R8、n和R9中的每一个具有在描述中定义的任何含义；它们的制备方法，含有它们的药物组合物以及它们在制造用于治疗细胞增殖紊乱的药物的药物中的使用。
• [EN] PYRROLOTRIAZINONE DERIVATIVES AS PI3K INHIBITORS<br/>[FR] DÉRIVÉS DE PYRROLOTRIAZINONE EN TANT QU'INHIBITEURS DES PI3K
  申请人：ALMIRALL SA

  公开号：WO2014060432A1

  公开（公告）日：2014-04-24

  New pyrrolotriazinone derivatives having the chemical structure of formula (I), are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks)

  新的吡咯三唑酮衍生物具有化学结构式（I），公开；以及它们的制备方法，包括它们的药物组合物和它们作为磷脂酰肌醇3-激酶（PI3Ks）抑制剂在治疗中的应用。
• A P,N-Ligand for Palladium-Catalyzed Ammonia Arylation: Coupling of Deactivated Aryl Chlorides, Chemoselective Arylations, and Room Temperature Reactions
  作者：Rylan J. Lundgren、Brendan D. Peters、Pamela G. Alsabeh、Mark Stradiotto

  DOI：10.1002/anie.201000526

  日期：2010.6.1

  Amazing ammonia: A new air‐stable P,N‐ligand (Mor‐DalPhos) is reported that enables the palladium‐catalyzed cross‐coupling of ammonia to a variety of aryl chloride and aryl tosylate substrates with high chemoselectivity and, for the first time, at room temperature (see scheme; Ad=adamantyl, Ts=para‐toluenesulfonyl).

  惊人的氨气：据报道，一种新型的空气稳定的P，N-配体（Mor-DalPhos）使钯催化的氨气与多种具有高化学选择性的芳基氯和甲苯磺酸芳基酯的交叉偶联成为首次。 ，在室温下（参见方案； Ad =金刚烷基，Ts =对甲苯磺酰基）。
• An Examination of the Palladium/Mor-DalPhos Catalyst System in the Context of Selective Ammonia Monoarylation at Room Temperature
  作者：Pamela G. Alsabeh、Rylan J. Lundgren、Robert McDonald、Carin C. C. Johansson Seechurn、Thomas J. Colacot、Mark Stradiotto

  DOI：10.1002/chem.201203640

  日期：2013.2.4

  (Mor‐DalPhos=di(1‐adamantyl)‐2‐morpholinophenylphosphine) catalyst system in Buchwald–Hartwig aminations employing ammonia was conducted to better understand the catalyst formation process and to guide the development of precatalysts for otherwise challenging room‐temperature ammonia monoarylations. The combination of [Pd(cinnamyl)Cl}2] and Mor‐DalPhos afforded [(κ2‐P,N‐Mor‐DalPhos)Pd(η1‐cinnamyl)Cl] (2)

  在使用氨的布赫瓦尔德-哈特维格胺胺化反应中，对[Pd（肉桂基）Cl} 2 ] / MOr-DalPhos（MOr-DalPhos =二（1-金刚烷基）-2-吗啉代苯基膦）催化剂体系进行了检查，以更好地理解该催化剂形成过程，并指导用于挑战室温氨单芳基化的预催化剂的开发。[的Pd（肉桂基）}氯的组合2 ]时，可以得到莫尔- DalPhos [（κ 2 - P，N -MOR-DalPhos）的Pd（η 1 -cinnamyl）CL]（2），其在存在碱和氯苯，生成[（κ 2 - P，ñ -MOR-DalPhos）的Pd（PH）CL]（1一）。从卤化物抽象1，得到[（κ 3 - P，N，O -MOR-DalPhos）的Pd（PH）]光学传递函数（5），带来的是由莫尔- DalPhos提供光的电位稳定的相互作用。的检查[（κ 2 - P，Ñ -MOR-DalPhos）的Pd（芳基）氯]（图1b -
• INDAZOLE COMPOUNDS AND USES THEREOF
  申请人：Incyte Corporation

  公开号：US20190256520A1

  公开（公告）日：2019-08-22

  Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.

  揭示了Formula (I)的化合物，使用这些化合物抑制HPK1活性的方法以及包含这些化合物的药物组合物。这些化合物在治疗、预防或改善与HPK1活性相关的疾病或障碍，如癌症方面是有用的。